ACC Limited announces the conclusion of Mr. A K Anand’s tenure as the Nominee Director of Life Insurance Corporation of India (LIC), effective September 15, 2025. This follows the completion of his term, as communicated in a letter from LIC dated August 28, 2025. Mr. Anand’s role ended at the close of business hours on the specified date.

Nominee Director Transition

Mr. A K Anand’s tenure as the Nominee Director representing the Life Insurance Corporation of India (LIC) on the Board of ACC Limited has officially ended on September 15, 2025. This change is based on the completion of his term, as per the official communication received from LIC on August 28, 2025.

Details of the Change

The cessation of Mr. Anand’s role was effective from the close of business hours on September 15, 2025. The company has confirmed that further details and related documents are available on its website.

Source: BSE

IRCON International Limited announces the successful commissioning of additional capacity at its Ircon Renewable Power Limited (IRPL) plant. An additional 100 MW (Lot-6) has been added, bringing the cumulative capacity to 400 MW out of a total 500 MW plant. IRPL is a 76% JV-Subsidiary of IRCON. This marks a significant step in IRCON’s renewable energy initiatives.

Renewable Energy Milestone

IRCON International Limited has announced a significant achievement in its renewable energy sector. The Ircon Renewable Power Limited (IRPL), a 76% JV-Subsidiary, has successfully commissioned an additional part capacity to its existing power plant.

Capacity Expansion Details

The newly commissioned capacity is 100 MW (Lot-6), increasing the total commissioned capacity to 400 MW. This addition is part of a larger 500 MW plant capacity. The announcement, dated September 15, 2025, reinforces IRCON’s commitment to expanding its footprint in the renewable energy sector.

Source: BSE

The Board of Directors of Bajaj Finserv approved amendments to the ‘Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information’ during their meeting on September 15, 2025. The revised Fair Disclosure Code will be available on the company website, and the company requested that the amended code be taken on record.

Fair Disclosure Code Amendment

The Board of Directors at Bajaj Finserv has officially approved changes to its internal policies. During a meeting held on September 15, 2025, the board approved amendments to the ‘Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information’ (Fair Disclosure Code).

Key Elements of the Fair Disclosure Code

The Fair Disclosure Code is designed to ensure prompt and consistent public disclosure of any information that could impact price discovery. The goal is to ensure that all information is generally available on a non-discriminatory basis. Key tenets of the code include:

• Ensuring uniform dissemination of information to avoid selective disclosure.
• Compliance Officer acting as Chief Investor Relations Officer (CIRO).
• Appropriate response to market rumors and news queries.
• Ensuring information shared with analysts is not Unpublished Price Sensitive Information (UPSI).

Legitimate Purposes for Information Sharing

The policy outlines the term “legitimate purposes” for sharing UPSI, clarifying that it includes sharing information with partners, collaborators, lenders, customers, suppliers, merchant bankers, legal advisors, auditors, insolvency professionals, and other advisors. However, such sharing must not be carried out to evade prohibitions under insider trading regulations.

Principles for Determining Legitimate Purpose

Key principles guide decisions on whether sharing UPSI is legitimate:

1. The person seeking information must have authority.
2. The person providing information must have authority.
3. The purpose for which information is sought must be disclosed.
4. Information should only be shared if it is necessary for the purpose.
5. The information should not be conditional or qualified.
6. Sharing should be consistent with regulatory requirements and past practices.

Maintenance and Review

Bajaj Finserv will maintain a structured digital database of individuals with whom UPSI is shared, including their Permanent Account Numbers. The policy is subject to periodic review to ensure it remains compliant with evolving regulatory requirements.

Source: BSE

Lemon Tree Hotels has signed a license agreement for a new Lemon Tree Hotel in Gaya, Bihar. The property, managed by Carnation Hotels Private Limited, will feature 56 well-appointed rooms, restaurants, a banquet, a meeting room, and various amenities. This addition strengthens Lemon Tree’s presence in Bihar and aligns with its expansion strategy, offering guests comfortable lodging options in a key location.

New Location Secured

Lemon Tree Hotels has announced the signing of a license agreement for a new property: Lemon Tree Hotel, Gaya, Bihar. The announcement was made on September 15, 2025. The hotel will be managed by Carnation Hotels Private Limited, a wholly-owned subsidiary of Lemon Tree Hotels Limited.

Hotel Features

The new Lemon Tree Hotel in Gaya will feature 56 well-appointed rooms. It will also include restaurants, a banquet hall, a meeting room, a swimming pool, a fitness center, and a spa, along with other public areas. The location is conveniently situated approximately 14 kms from the Bodhgaya Airport and about 6 kms from the Gaya Railway Station.

Strategic Expansion

Kapil Sharma, Executive Vice President – Finance & Chief Financial Officer of Lemon Tree Hotels, stated that this signing will further enhance the company’s footprint in Bihar. He added that the expansion aligns with the company’s strategy to expand its brand across the country and provide guests with comfortable options.

Lemon Tree Hotels Overview

Lemon Tree Hotels Limited (LTHL) operates over 110 hotels across 75+ cities in India and abroad, with over 110 upcoming properties. The company offers a range of brands, including Aurika Hotels & Resorts and Lemon Tree Premier, catering to diverse traveller segments.

Source: BSE

UPL has received ₹1,671.79 crore, representing approximately 99% of the total amount due on the Second and Final Call, for 9,27,15,506 partly paid-up equity shares. The company fixed August 1, 2025, as the record date for this payment. Fully paid-up equity shares of ₹2 each are now available for trading, effective September 16, 2025.

Second and Final Call Money Received

UPL Limited announced the successful receipt of the Second and Final Call money related to its partly paid-up equity shares. The company received a substantial amount, marking a significant milestone in its financial operations.

Key Dates and Figures

The record date for the payment was August 1, 2025. The total amount received is ₹1,671.79 crore, which accounts for approximately 99% of the total amount due on the Second and Final Call. This covers 9,27,15,506 partly paid-up equity shares.

Trading Availability

Following the completion of necessary corporate actions, the company’s equity shares with a face value of ₹2 each are now fully paid-up and available for trading on the Stock Exchanges starting September 16, 2025. The ISIN is INE628A01036.

Source: BSE

Ambuja Cements announces the conclusion of Mr. M R Kumar’s tenure as the Nominee Director of Life Insurance Corporation of India (LIC) on the Board, effective September 15, 2025. This follows the completion of his term, as indicated in a letter received from LIC dated August 21, 2025. The resignation letter from Mr. Kumar has been received.

Nominee Director’s Departure

Mr. M R Kumar’s tenure as the Life Insurance Corporation of India (LIC) Nominee Director on the Board of Ambuja Cements has concluded. The effective date of this change is September 15, 2025.

Details of the Transition

The company received official communication from LIC on August 21, 2025, confirming the completion of Mr. Kumar’s term. His resignation is effective from the close of business hours on September 15, 2025.

Additional Information

The cessation is due to the completion of tenure, according to the provided details. A copy of the resignation letter from Mr. M R Kumar is included with this announcement.

Source: BSE

Indian Bank has confirmed the successful payment of interest on its Long Term Infrastructure Bonds Series I (ISIN – INE562A08099) due on September 15, 2025. The interest payment, amounting to Rs.362,00,00,000/-, was made to the bondholders. This announcement assures investors of the bank’s commitment to fulfilling its financial obligations related to its debt securities.

Interest Payment on Debt Securities

Indian Bank confirms that the interest payment for Long Term Infrastructure Bonds Series I (ISIN – INE562A08099) has been successfully completed. The payment was due on September 15, 2025. This reflects the bank’s adherence to its financial commitments regarding debt securities.

Details of Interest Payment

The key details of the interest payment are as follows:

• ISIN: INE562A08099
• Issue Size: Rs.5000 Crore
• Interest Amount Paid: Rs.362,00,00,000/-
• Payment Frequency: Annually
• Interest Payment Record Date: 29.08.2025
• Due Date for Interest Payment: 15.09.2025
• Actual Date of Payment: 15.09.2025

Timely Payment Clarification

The original due date for the interest payment was September 13, 2025, a Saturday (holiday). Since September 14, 2025 was a Sunday, the interest was paid on the subsequent business day, September 15, 2025, without any additional interest, according to the offer document’s terms.

Source: BSE

NHPC Limited has announced the appointment of its Joint Statutory Auditors for the financial year 2025-26. The firms of Chartered Accountants that served as Joint Statutory Auditors for the previous year will continue in their roles. This appointment ensures the audit of both standalone and consolidated financial statements for the company.

Auditor Appointments

NHPC Limited has appointed its Joint Statutory Auditors for the financial year 2025-26. The following firms of Chartered Accountants have been appointed:

• M/s S N Dhawan & Co. LLP, New Delhi
• M/s S Jaykishan, Kolkata
• M/s Dharam Raj & Co., Jammu

Scope of Audit

These Joint Statutory Auditors will also audit the Consolidated Financial Statements of the Company. The appointments adhere to the guidelines set forth in the Companies Act, 2013. Profiles for each auditor have been provided below.

About S.N. Dhawan & Co LLP

S.N. Dhawan & CO LLP, established in 1944, is a Chartered Accountancy firm in India with experience in sectors including Manufacturing, Retail, Power, FMCG, Real Estate, Construction, Infrastructure, IT and Engineering. The firm is registered with the Comptroller and Auditor General of India and the Reserve Bank of India for audits of public sector undertakings and Banks.

About S Jaykishan

S Jaykishan has been a financial partner for corporates, banks, and government institutions for five decades. They specialize in Assurance, Taxation, Risk Management, Forensic Investigations, and Business Advisory.

About Dharam Raj & Co.

Dharam Raj & Co. has 28 years of experience in sectors including Banking, Public Sector Undertaking, Power and energy, Oil and Gas, healthcare, textiles, insurance, Infrastructure, Telecom, Tourism, Construction, and Technology. The firm is registered with the Comptroller and Auditor General of India and the Reserve Bank of India for audits of large public sector undertakings & Banks.

Source: BSE

Zydus Lifesciences’ animal health division, ZyVet, has launched the first FDA-approved generic treatment for canine urinary incontinence and an affordable generic version of Furosemide tablets for long-term heart care in dogs and cats. These launches underscore ZyVet’s mission to provide trusted, high-quality, and cost-effective therapies to veterinary professionals.

Expanding Affordable Veterinary Treatments

ZyVet Animal Health, a division of Zydus Lifesciences, has introduced two new generic medications aimed at improving the accessibility and affordability of veterinary treatments. The new offerings include treatments for canine urinary incontinence and long-term heart care for dogs and cats.

First Generic for Canine Urinary Incontinence

ZyVet has launched the first FDA-approved generic of phenylpropanolamine hydrochloride tablets, a trusted treatment for managing urinary incontinence in dogs. This medication addresses urethral sphincter hypotonus, a common issue in spayed females and aging dogs, offering reliable symptom relief and supporting client compliance. The product is available in multiple strengths for precise dosing.

Affordable Furosemide Tablets for Heart Care

The company also introduced affordable Furosemide tablets, a generic version of a trusted diuretic for dogs and cats needing long-term heart care. This medication supports the reduction of edema and pulmonary congestion due to cardiac, renal, or systemic disease. It provides veterinarians a consistent, cost-effective solution without compromising dosing flexibility or product availability.

ZyVet’s Commitment to Affordable Innovation

These launches reinforce ZyVet’s commitment to providing affordable innovation to the veterinary market, ensuring that high-quality treatments are accessible to more pet owners. Punit Patel, President and CEO, Zydus Americas, emphasized that the company is proud to offer options that remove cost as a barrier to compassionate care.

Driving Paradigm Shift in the Industry

ZyVet’s expansion reinforces that generic animal health products are as effective as pioneer brands. ZyVet benefits from more than 70 years of pharmaceutical R&D, Regulatory, QA/QC, manufacturing scale, excellence and expertise.

Source: BSE

WAAREE Energies announces that its wholly-owned subsidiary, Rasila International Pte Ltd, incorporated in Singapore, has been struck off from the Accounting & Corporate Regulatory Authority effective August 09, 2025. Consequently, Rasila International Pte Ltd has ceased to be a subsidiary. The company has provided details as per stipulated regulations, confirming compliance. The subsidiary was a dormant entity, with no financial impact.

Singapore Subsidiary Closure

WAAREE Energies Ltd. has announced the cessation of operations for its wholly-owned subsidiary, Rasila International Pte Ltd, based in Singapore. The subsidiary was officially struck off from the records of the Accounting & Corporate Regulatory Authority on August 09, 2025.

Details of the Closure

Rasila International Pte Ltd. was a dormant entity, and its closure has minimal impact on WAAREE Energies. There were no transactions or ongoing projects associated with the subsidiary at the time of closure. The subsidiary contributed no turnover, revenue, income, or net worth in the last financial year (2024-25). The effective date of this change is August 09, 2025.

Compliance Information

WAAREE Energies has confirmed that the closure of Rasila International Pte Ltd complies with all regulatory requirements. The company has provided the necessary disclosures and affirms that the transaction does not involve any related parties or require special considerations.

Source: BSE